Several pages imply or state that IND status means some level of FDA endorsement
Whether that translates into additive weight loss in humans is the open empirical question
An experts knowledge can be useful here
J., Jdar, E., & Rosenstock, J
How PlexusDx Supports a More Personalized Approach PlexusDx recognizes that Wegovy's high uninsured cost ($900$1,500/month) creates real barriers to care
Key Benefits: - Once-a-week dosing for convenience - Helps lower blood sugar levels - Reduces the risk of heart attack, stroke, and death in people with heart disease - Easy-to-use pre-filled pen for simple administration How It Works: Sem P Once A Week contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist